Click for best price
Pharmacokinetics Services Market Size, Share 2024
| Market size in 2023 |
US$ 586.8 million
|
Forecast Market size by 2030 |
US$ 846.5 million
|
| Growth Rate |
CAGR of 4.9% |
Number of Pages |
112 Pages |
The global Pharmacokinetics Services market was valued at US$ 586.8 million in 2023 and is projected to reach US$ 846.5 million by 2030, at a CAGR of 4.9% during the forecast period.
The USA market for Global Pharmacokinetics Services market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Pharmacokinetics Services market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Pharmacokinetics Services market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
This research report provides a comprehensive analysis of the Pharmacokinetics Services market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Pharmacokinetics Services market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Pharmacokinetics Services, challenges faced by the industry, and potential opportunities for market players.
The global Pharmacokinetics Services market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Pharmacokinetics Services market presents opportunities for various stakeholders, including Small & Medium Enterprise, Large Enterprise. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Pharmacokinetics Services market. Additionally, the growing consumer demand present avenues for market expansion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Pharmacokinetics Services market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Pharmacokinetics Services market.
Market Overview: The report provides a comprehensive overview of the Pharmacokinetics Services market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Small Molecules Pharmacokinetics Services, Large Molecules (Biopharmaceuticals) Pharmacokinetics Services), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Pharmacokinetics Services market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Pharmacokinetics Services market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Pharmacokinetics Services market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Pharmacokinetics Services market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Pharmacokinetics Services market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Pharmacokinetics Services market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Pharmacokinetics Services, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Pharmacokinetics Services market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Pharmacokinetics Services market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Small Molecules Pharmacokinetics Services
- Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
Market segment by Application
- Small & Medium Enterprise
- Large Enterprise
Global Pharmacokinetics Services Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Major players covered
- Evotec AG (Germany)
- Pacific BioLabs (US)
- GVK Biosciences Private Limited (India)
- Shanghai Medicilon Inc. (China)
- Pharmaceutical Product Development, LLC (US)
- Charles River Laboratories International, Inc. (US)
- PAREXEL International Corporation (US)
- Eurofins Scientific, Inc. (Luxembourg)
- Frontage Labs (US)
- SGS SA (Switzerland)
- LGC Limited (UK)
- Creative Bioarray (US)
- Certara, L.P. (Germany)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pharmacokinetics Services, market overview.
Chapter 2: Global Pharmacokinetics Services market size in revenue.
Chapter 3: Detailed analysis of Pharmacokinetics Services company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pharmacokinetics Services in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Pharmacokinetics Services Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 586.8 million
|
| Forecast Market size by 2030 |
US$ 846.5 million
|
| Growth Rate |
CAGR of 4.9% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
112 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Pharmacokinetics Services Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pharmacokinetics Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pharmacokinetics Services Overall Market Size
2.1 Global Pharmacokinetics Services Market Size: 2023 VS 2030
2.2 Global Pharmacokinetics Services Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pharmacokinetics Services Players in Global Market
3.2 Top Global Pharmacokinetics Services Companies Ranked by Revenue
3.3 Global Pharmacokinetics Services Revenue by Companies
3.4 Top 3 and Top 5 Pharmacokinetics Services Companies in Global Market, by Revenue in 2023
3.5 Global Companies Pharmacokinetics Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pharmacokinetics Services Players in Global Market
3.6.1 List of Global Tier 1 Pharmacokinetics Services Companies
3.6.2 List of Global Tier 2 and Tier 3 Pharmacokinetics Services Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Pharmacokinetics Services Market Size Markets, 2023 & 2030
4.1.2 Small Molecules Pharmacokinetics Services
4.1.3 Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
4.2 By Type - Global Pharmacokinetics Services Revenue & Forecasts
4.2.1 By Type - Global Pharmacokinetics Services Revenue, 2019-2024
4.2.2 By Type - Global Pharmacokinetics Services Revenue, 2025-2030
4.2.3 By Type - Global Pharmacokinetics Services Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pharmacokinetics Services Market Size, 2023 & 2030
5.1.2 Small & Medium Enterprise
5.1.3 Large Enterprise
5.2 By Application - Global Pharmacokinetics Services Revenue & Forecasts
5.2.1 By Application - Global Pharmacokinetics Services Revenue, 2019-2024
5.2.2 By Application - Global Pharmacokinetics Services Revenue, 2025-2030
5.2.3 By Application - Global Pharmacokinetics Services Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Pharmacokinetics Services Market Size, 2023 & 2030
6.2 By Region - Global Pharmacokinetics Services Revenue & Forecasts
6.2.1 By Region - Global Pharmacokinetics Services Revenue, 2019-2024
6.2.2 By Region - Global Pharmacokinetics Services Revenue, 2025-2030
6.2.3 By Region - Global Pharmacokinetics Services Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Pharmacokinetics Services Revenue, 2019-2030
6.3.2 US Pharmacokinetics Services Market Size, 2019-2030
6.3.3 Canada Pharmacokinetics Services Market Size, 2019-2030
6.3.4 Mexico Pharmacokinetics Services Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Pharmacokinetics Services Revenue, 2019-2030
6.4.2 Germany Pharmacokinetics Services Market Size, 2019-2030
6.4.3 France Pharmacokinetics Services Market Size, 2019-2030
6.4.4 U.K. Pharmacokinetics Services Market Size, 2019-2030
6.4.5 Italy Pharmacokinetics Services Market Size, 2019-2030
6.4.6 Russia Pharmacokinetics Services Market Size, 2019-2030
6.4.7 Nordic Countries Pharmacokinetics Services Market Size, 2019-2030
6.4.8 Benelux Pharmacokinetics Services Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Pharmacokinetics Services Revenue, 2019-2030
6.5.2 China Pharmacokinetics Services Market Size, 2019-2030
6.5.3 Japan Pharmacokinetics Services Market Size, 2019-2030
6.5.4 South Korea Pharmacokinetics Services Market Size, 2019-2030
6.5.5 Southeast Asia Pharmacokinetics Services Market Size, 2019-2030
6.5.6 India Pharmacokinetics Services Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Pharmacokinetics Services Revenue, 2019-2030
6.6.2 Brazil Pharmacokinetics Services Market Size, 2019-2030
6.6.3 Argentina Pharmacokinetics Services Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pharmacokinetics Services Revenue, 2019-2030
6.7.2 Turkey Pharmacokinetics Services Market Size, 2019-2030
6.7.3 Israel Pharmacokinetics Services Market Size, 2019-2030
6.7.4 Saudi Arabia Pharmacokinetics Services Market Size, 2019-2030
6.7.5 UAE Pharmacokinetics Services Market Size, 2019-2030
7 Pharmacokinetics Services Companies Profiles
7.1 Evotec AG (Germany)
7.1.1 Evotec AG (Germany) Company Summary
7.1.2 Evotec AG (Germany) Business Overview
7.1.3 Evotec AG (Germany) Pharmacokinetics Services Major Product Offerings
7.1.4 Evotec AG (Germany) Pharmacokinetics Services Revenue in Global Market (2019-2024)
7.1.5 Evotec AG (Germany) Key News & Latest Developments
7.2 Pacific BioLabs (US)
7.2.1 Pacific BioLabs (US) Company Summary
7.2.2 Pacific BioLabs (US) Business Overview
7.2.3 Pacific BioLabs (US) Pharmacokinetics Services Major Product Offerings
7.2.4 Pacific BioLabs (US) Pharmacokinetics Services Revenue in Global Market (2019-2024)
7.2.5 Pacific BioLabs (US) Key News & Latest Developments
7.3 GVK Biosciences Private Limited (India)
7.3.1 GVK Biosciences Private Limited (India) Company Summary
7.3.2 GVK Biosciences Private Limited (India) Business Overview
7.3.3 GVK Biosciences Private Limited (India) Pharmacokinetics Services Major Product Offerings
7.3.4 GVK Biosciences Private Limited (India) Pharmacokinetics Services Revenue in Global Market (2019-2024)
7.3.5 GVK Biosciences Private Limited (India) Key News & Latest Developments
7.4 Shanghai Medicilon Inc. (China)
7.4.1 Shanghai Medicilon Inc. (China) Company Summary
7.4.2 Shanghai Medicilon Inc. (China) Business Overview
7.4.3 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Major Product Offerings
7.4.4 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Revenue in Global Market (2019-2024)
7.4.5 Shanghai Medicilon Inc. (China) Key News & Latest Developments
7.5 Pharmaceutical Product Development, LLC (US)
7.5.1 Pharmaceutical Product Development, LLC (US) Company Summary
7.5.2 Pharmaceutical Product Development, LLC (US) Business Overview
7.5.3 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Major Product Offerings
7.5.4 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Revenue in Global Market (2019-2024)
7.5.5 Pharmaceutical Product Development, LLC (US) Key News & Latest Developments
7.6 Charles River Laboratories International, Inc. (US)
7.6.1 Charles River Laboratories International, Inc. (US) Company Summary
7.6.2 Charles River Laboratories International, Inc. (US) Business Overview
7.6.3 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Major Product Offerings
7.6.4 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Revenue in Global Market (2019-2024)
7.6.5 Charles River Laboratories International, Inc. (US) Key News & Latest Developments
7.7 PAREXEL International Corporation (US)
7.7.1 PAREXEL International Corporation (US) Company Summary
7.7.2 PAREXEL International Corporation (US) Business Overview
7.7.3 PAREXEL International Corporation (US) Pharmacokinetics Services Major Product Offerings
7.7.4 PAREXEL International Corporation (US) Pharmacokinetics Services Revenue in Global Market (2019-2024)
7.7.5 PAREXEL International Corporation (US) Key News & Latest Developments
7.8 Eurofins Scientific, Inc. (Luxembourg)
7.8.1 Eurofins Scientific, Inc. (Luxembourg) Company Summary
7.8.2 Eurofins Scientific, Inc. (Luxembourg) Business Overview
7.8.3 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Major Product Offerings
7.8.4 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Revenue in Global Market (2019-2024)
7.8.5 Eurofins Scientific, Inc. (Luxembourg) Key News & Latest Developments
7.9 Frontage Labs (US)
7.9.1 Frontage Labs (US) Company Summary
7.9.2 Frontage Labs (US) Business Overview
7.9.3 Frontage Labs (US) Pharmacokinetics Services Major Product Offerings
7.9.4 Frontage Labs (US) Pharmacokinetics Services Revenue in Global Market (2019-2024)
7.9.5 Frontage Labs (US) Key News & Latest Developments
7.10 SGS SA (Switzerland)
7.10.1 SGS SA (Switzerland) Company Summary
7.10.2 SGS SA (Switzerland) Business Overview
7.10.3 SGS SA (Switzerland) Pharmacokinetics Services Major Product Offerings
7.10.4 SGS SA (Switzerland) Pharmacokinetics Services Revenue in Global Market (2019-2024)
7.10.5 SGS SA (Switzerland) Key News & Latest Developments
7.11 LGC Limited (UK)
7.11.1 LGC Limited (UK) Company Summary
7.11.2 LGC Limited (UK) Business Overview
7.11.3 LGC Limited (UK) Pharmacokinetics Services Major Product Offerings
7.11.4 LGC Limited (UK) Pharmacokinetics Services Revenue in Global Market (2019-2024)
7.11.5 LGC Limited (UK) Key News & Latest Developments
7.12 Creative Bioarray (US)
7.12.1 Creative Bioarray (US) Company Summary
7.12.2 Creative Bioarray (US) Business Overview
7.12.3 Creative Bioarray (US) Pharmacokinetics Services Major Product Offerings
7.12.4 Creative Bioarray (US) Pharmacokinetics Services Revenue in Global Market (2019-2024)
7.12.5 Creative Bioarray (US) Key News & Latest Developments
7.13 Certara, L.P. (Germany)
7.13.1 Certara, L.P. (Germany) Company Summary
7.13.2 Certara, L.P. (Germany) Business Overview
7.13.3 Certara, L.P. (Germany) Pharmacokinetics Services Major Product Offerings
7.13.4 Certara, L.P. (Germany) Pharmacokinetics Services Revenue in Global Market (2019-2024)
7.13.5 Certara, L.P. (Germany) Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Pharmacokinetics Services Market Opportunities & Trends in Global Market
Table 2. Pharmacokinetics Services Market Drivers in Global Market
Table 3. Pharmacokinetics Services Market Restraints in Global Market
Table 4. Key Players of Pharmacokinetics Services in Global Market
Table 5. Top Pharmacokinetics Services Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Pharmacokinetics Services Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Pharmacokinetics Services Revenue Share by Companies, 2019-2024
Table 8. Global Companies Pharmacokinetics Services Product Type
Table 9. List of Global Tier 1 Pharmacokinetics Services Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pharmacokinetics Services Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Pharmacokinetics Services Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Pharmacokinetics Services Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Pharmacokinetics Services Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Pharmacokinetics Services Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Pharmacokinetics Services Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Pharmacokinetics Services Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Pharmacokinetics Services Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Pharmacokinetics Services Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Pharmacokinetics Services Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Pharmacokinetics Services Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Pharmacokinetics Services Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Pharmacokinetics Services Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Pharmacokinetics Services Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Pharmacokinetics Services Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Pharmacokinetics Services Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Pharmacokinetics Services Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Pharmacokinetics Services Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Pharmacokinetics Services Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Pharmacokinetics Services Revenue, (US$, Mn), 2025-2030
Table 30. Evotec AG (Germany) Company Summary
Table 31. Evotec AG (Germany) Pharmacokinetics Services Product Offerings
Table 32. Evotec AG (Germany) Pharmacokinetics Services Revenue (US$, Mn) & (2019-2024)
Table 33. Evotec AG (Germany) Key News & Latest Developments
Table 34. Pacific BioLabs (US) Company Summary
Table 35. Pacific BioLabs (US) Pharmacokinetics Services Product Offerings
Table 36. Pacific BioLabs (US) Pharmacokinetics Services Revenue (US$, Mn) & (2019-2024)
Table 37. Pacific BioLabs (US) Key News & Latest Developments
Table 38. GVK Biosciences Private Limited (India) Company Summary
Table 39. GVK Biosciences Private Limited (India) Pharmacokinetics Services Product Offerings
Table 40. GVK Biosciences Private Limited (India) Pharmacokinetics Services Revenue (US$, Mn) & (2019-2024)
Table 41. GVK Biosciences Private Limited (India) Key News & Latest Developments
Table 42. Shanghai Medicilon Inc. (China) Company Summary
Table 43. Shanghai Medicilon Inc. (China) Pharmacokinetics Services Product Offerings
Table 44. Shanghai Medicilon Inc. (China) Pharmacokinetics Services Revenue (US$, Mn) & (2019-2024)
Table 45. Shanghai Medicilon Inc. (China) Key News & Latest Developments
Table 46. Pharmaceutical Product Development, LLC (US) Company Summary
Table 47. Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Product Offerings
Table 48. Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Revenue (US$, Mn) & (2019-2024)
Table 49. Pharmaceutical Product Development, LLC (US) Key News & Latest Developments
Table 50. Charles River Laboratories International, Inc. (US) Company Summary
Table 51. Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Product Offerings
Table 52. Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Revenue (US$, Mn) & (2019-2024)
Table 53. Charles River Laboratories International, Inc. (US) Key News & Latest Developments
Table 54. PAREXEL International Corporation (US) Company Summary
Table 55. PAREXEL International Corporation (US) Pharmacokinetics Services Product Offerings
Table 56. PAREXEL International Corporation (US) Pharmacokinetics Services Revenue (US$, Mn) & (2019-2024)
Table 57. PAREXEL International Corporation (US) Key News & Latest Developments
Table 58. Eurofins Scientific, Inc. (Luxembourg) Company Summary
Table 59. Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Product Offerings
Table 60. Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Revenue (US$, Mn) & (2019-2024)
Table 61. Eurofins Scientific, Inc. (Luxembourg) Key News & Latest Developments
Table 62. Frontage Labs (US) Company Summary
Table 63. Frontage Labs (US) Pharmacokinetics Services Product Offerings
Table 64. Frontage Labs (US) Pharmacokinetics Services Revenue (US$, Mn) & (2019-2024)
Table 65. Frontage Labs (US) Key News & Latest Developments
Table 66. SGS SA (Switzerland) Company Summary
Table 67. SGS SA (Switzerland) Pharmacokinetics Services Product Offerings
Table 68. SGS SA (Switzerland) Pharmacokinetics Services Revenue (US$, Mn) & (2019-2024)
Table 69. SGS SA (Switzerland) Key News & Latest Developments
Table 70. LGC Limited (UK) Company Summary
Table 71. LGC Limited (UK) Pharmacokinetics Services Product Offerings
Table 72. LGC Limited (UK) Pharmacokinetics Services Revenue (US$, Mn) & (2019-2024)
Table 73. LGC Limited (UK) Key News & Latest Developments
Table 74. Creative Bioarray (US) Company Summary
Table 75. Creative Bioarray (US) Pharmacokinetics Services Product Offerings
Table 76. Creative Bioarray (US) Pharmacokinetics Services Revenue (US$, Mn) & (2019-2024)
Table 77. Creative Bioarray (US) Key News & Latest Developments
Table 78. Certara, L.P. (Germany) Company Summary
Table 79. Certara, L.P. (Germany) Pharmacokinetics Services Product Offerings
Table 80. Certara, L.P. (Germany) Pharmacokinetics Services Revenue (US$, Mn) & (2019-2024)
Table 81. Certara, L.P. (Germany) Key News & Latest Developments
List of Figures
Figure 1. Pharmacokinetics Services Segment by Type in 2023
Figure 2. Pharmacokinetics Services Segment by Application in 2023
Figure 3. Global Pharmacokinetics Services Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Pharmacokinetics Services Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Pharmacokinetics Services Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pharmacokinetics Services Revenue in 2023
Figure 8. By Type - Global Pharmacokinetics Services Revenue Market Share, 2019-2030
Figure 9. By Application - Global Pharmacokinetics Services Revenue Market Share, 2019-2030
Figure 10. By Type - Global Pharmacokinetics Services Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Pharmacokinetics Services Revenue Market Share, 2019-2030
Figure 12. By Application - Global Pharmacokinetics Services Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Pharmacokinetics Services Revenue Market Share, 2019-2030
Figure 14. By Region - Global Pharmacokinetics Services Revenue Market Share, 2019-2030
Figure 15. By Country - North America Pharmacokinetics Services Revenue Market Share, 2019-2030
Figure 16. US Pharmacokinetics Services Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Pharmacokinetics Services Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Pharmacokinetics Services Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Pharmacokinetics Services Revenue Market Share, 2019-2030
Figure 20. Germany Pharmacokinetics Services Revenue, (US$, Mn), 2019-2030
Figure 21. France Pharmacokinetics Services Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Pharmacokinetics Services Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Pharmacokinetics Services Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Pharmacokinetics Services Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Pharmacokinetics Services Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Pharmacokinetics Services Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Pharmacokinetics Services Revenue Market Share, 2019-2030
Figure 28. China Pharmacokinetics Services Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Pharmacokinetics Services Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Pharmacokinetics Services Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Pharmacokinetics Services Revenue, (US$, Mn), 2019-2030
Figure 32. India Pharmacokinetics Services Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Pharmacokinetics Services Revenue Market Share, 2019-2030
Figure 34. Brazil Pharmacokinetics Services Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Pharmacokinetics Services Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Pharmacokinetics Services Revenue Market Share, 2019-2030
Figure 37. Turkey Pharmacokinetics Services Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Pharmacokinetics Services Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Pharmacokinetics Services Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Pharmacokinetics Services Revenue, (US$, Mn), 2019-2030
Figure 41. Evotec AG (Germany) Pharmacokinetics Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Pacific BioLabs (US) Pharmacokinetics Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. GVK Biosciences Private Limited (India) Pharmacokinetics Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Shanghai Medicilon Inc. (China) Pharmacokinetics Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. PAREXEL International Corporation (US) Pharmacokinetics Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Frontage Labs (US) Pharmacokinetics Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. SGS SA (Switzerland) Pharmacokinetics Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. LGC Limited (UK) Pharmacokinetics Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Creative Bioarray (US) Pharmacokinetics Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Certara, L.P. (Germany) Pharmacokinetics Services Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
